Home/Filings/4/0001441844-10-000083
4//SEC Filing

MADDON PAUL J 4

Accession 0001441844-10-000083

CIK 0000835887other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 4:12 PM ET

Size

5.4 KB

Accession

0001441844-10-000083

Insider Transaction Report

Form 4
Period: 2010-12-01
MADDON PAUL J
Chief Executive Officer/CSO10% Owner
Transactions
  • Purchase

    Common Stock

    2010-12-01$4.90/sh+5,000$24,500854,057 total
Footnotes (2)
  • [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • [F2]This transaction was executed in multiple trades at prices ranging from $4.85 to $4.98. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1
  • filerCIK 0001250313

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:12 PM ET
Size
5.4 KB